ACH

Business Context and Reporting Period

This summary covers the Form 10-Q for Owens & Minor, Inc. (Note: The input metadata listed "Accendra Health Inc," but the filing text explicitly identifies the registrant as Owens & Minor, Inc.). The report covers the quarterly period ended March 31, 2007. Owens & Minor is a distributor of medical and surgical supplies, operating primarily in the acute-care and direct-to-consumer (DTC) sectors. A significant event during this period was the completion of the transition for the acquisition of the acute-care distribution business from McKesson Medical-Surgical Inc., finalized in March 2007.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 33.6% ($424.2 million) year-over-year. Approximately two-thirds of this increase ($282.5 million) was attributable to the acquired McKesson business, with the remainder driven by higher sales volume to existing customers.
• Profitability Decline: Despite revenue growth, Net Income decreased 34.5% to $10.8 million. Operating earnings fell 18.5% to $24.8 million. Management attributes this primarily to $8.1 million in "dilution" (pre-tax net loss) from the acquired McKesson business during its transition period.
• Margin Compression: Gross margin percentage declined from 10.8% to 10.4%. Factors included lower margins on the acquired business, reduced supplier incentives, and contract renewals with group purchasing organizations offering favorable pricing to customers.
• Expense Increases: Selling, General, and Administrative (SG&A) expenses rose to 8.5% of revenue from 8.0%, driven by integration costs, transition fees paid to McKesson, and increased allowances for doubtful accounts related to the acquired business. Net interest expense more than doubled to $7.2 million due to borrowings used to fund the acquisition.
• Cash Flow: Operating cash flow turned negative ($3.3 million used) compared to a positive $21.6 million in the prior year, largely due to timing of inventory payments and increases in accounts receivable.

Guidance, Outlook, Risks, and Unusual Items

• Acquisition Integration: The company completed the transition of the McKesson acute-care business in March 2007. While this drove revenue, it negatively impacted earnings and cash flow in the short term due to integration costs and lower initial margins.
• Direct-to-Consumer (DTC) Segment: The DTC business contributed $26.9 million in revenue (up from $17.8 million) but recorded an operating loss of $1.0 million. This segment has higher gross margins but also significantly higher SG&A expenses.
• Debt and Liquidity: On January 29, 2007, the company amended its revolving credit facility, increasing capacity from $250 million to $350 million. As of March 31, 2007, $254.4 million was outstanding, leaving $82.5 million available. The company holds an investment-grade credit rating (BBB-).
• Material Contingency (IRS Dispute): The IRS has proposed disallowing certain LIFO inventory valuation reductions effective from 2001. If unsuccessful in its appeal, the company faces a potential tax deficiency of approximately $68.3 million plus interest of $10.4 million. No reserve has been established for this amount.
• Accounting Changes: The company adopted FASB Interpretation No. 48 (FIN 48) on January 1, 2007, resulting in a $0.8 million decrease in unrecognized tax benefits and a corresponding increase to retained earnings. Additionally, amortization of direct-response advertising costs was reclassified from depreciation to SG&A expenses.

Investor Verification Checklist

• IRS LIFO Dispute: Verify the status of the appeal regarding the $68.3 million potential tax deficiency and the likelihood of a material cash outflow.
• McKesson Integration Progress: Monitor subsequent quarters for the stabilization of gross margins and the reduction of integration-related SG&A expenses in the acquired acute-care business.
• Working Capital Trends: Review Days Sales Outstanding (DSO), which increased to 29.7 days, and inventory turnover, which declined to 9.2, to assess collection efficiency and inventory management post-acquisition.
• Debt Covenants: Confirm that the increased leverage from the acquisition remains within the covenants of the amended $350 million credit facility.
• DTC Profitability: Assess whether the Direct-to-Consumer segment can achieve profitability given its current operating losses despite revenue growth.